Biogenetic cantharidin is a promising leading compound to manage insecticide resistance of Mythimna separata (Lepidoptera: Noctuidae)

Yifan Li,Hong Sun,Hassan Yasoob,Zhen Tian,Yue Li,Ruichi Li,Shengli Zheng,Jiyuan Liu,Yalin Zhang
DOI: https://doi.org/10.1016/j.pestbp.2020.104769
IF: 4.966
2021-02-01
Pesticide Biochemistry and Physiology
Abstract:<p>Cantharidin (CTD) is a natural toxin with effective toxicity to lepidopteran pests. Nevertheless, little information is available on whether pests develop resistance to CTD. After being exposed to CTD (50 mg/L to 90 mg/L) or 10 generations, the resistance ratio of laboratory selected cantharidin-resistant <em>Mythimna separata</em> (Cantharidin-SEL) strain was only elevated 1.95-fold. Meanwhile, the developmental time for <em>M. separata</em> was prolonged (delayed1.65 in males and 1.84 days in females). The reported CTD target, the serine/threonine phosphatases (PSPs), have not been shown significant activity variation during the whole process of CTD-treatment. The activity of detoxification enzymes (cytochrome monooxygenase P450, glutathione-S-transferase (GST) and carboxylesterase) were affected by CTD selection, but this change was not mathematically significant. More importantly, no obvious cross-resistance with other commonly used insecticides was observed in the <em>M. separata</em> population treated with CTD for 10 generations (resistance ratios were all lower 2.5). Overall, <em>M. separata</em> is unlikely to produce target-site insensitivity resistance, metabolic resistance to CTD. Meanwhile, cantharidin-SEL is not prone to develop cross-resistance with other insecticides. These results indicate that CTD is a promising biogenetic lead compound which can be applied in the resistance management on <em>M. separata</em>.</p>
biochemistry & molecular biology,entomology,physiology
What problem does this paper attempt to address?